Cephalalgia

Papers
(The H4-Index of Cephalalgia is 28. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-05-01 to 2025-05-01.)
ArticleCitations
Chronic Migraine Epidemiology and Outcomes – International (CaMEO-I) Study: Methods and multi-country baseline findings for diagnosis rates and care109
Harassment in the headache field: a global web-based cross-sectional survey86
International Classification of Headache Disorders-4 – Work in Progress 175
A reply, drug-induced reversible cerebral vasoconstriction syndrome: Lessons from the real world75
Fremanezumab for the Preventive Treatment of Migraine: Subgroup Analysis by Number of Prior Preventive Treatments with Inadequate Response67
High perceived isolation and reduced social support affect headache impact levels in migraine after the Covid-19 outbreak: A cross sectional survey on chronic and episodic patients61
Evaluating the efficacy of CGRP mAbs and gepants for the preventive treatment of migraine: A systematic review and network meta-analysis of phase 3 randomised controlled trials60
Efficacy and tolerability of combination treatment of topiramate and greater occipital nerve block versus topiramate monotherapy for the preventive treatment of chronic migraine: A randomized controll59
Evidence-based guidelines for the pharmacological treatment of migraine56
Population-based prevalence of cranial autonomic symptoms in migraine and proposed diagnostic appendix criteria54
Depression screening in migraine - A double-edged sword53
Assessing migraine therapeutics50
Genome-wide DNA methylation analysis in an antimigraine-treated preclinical model of cortical spreading depolarization48
Comment on “What predicts citation counts and translational impact in headache research? A machine learning analysis”43
Call for papers42
Corrigendum to: Evaluation of outcomes of calcitonin gene-related peptide (CGRP)-targeting therapies for acute and preventive migraine treatment based on patient sex41
Systemic lupus erythematosus mimicking retinal migraine: a case report39
Diagnosis of idiopathic intracranial hypertension - the importance of excluding secondary causes: A systematic review39
The effects of certain TRP channels and voltage-gated KCNQ/Kv7 channel opener retigabine on calcitonin gene-related peptide release in the trigeminovascular system38
Guidelines of the International Headache Society for controlled trials of pharmacological preventive treatment for persistent post-traumatic headache attributed to mild traumatic brain injury37
Letter to the editor regarding “Safety profile of erenumab, galcanezumab and fremanezumab in pregnancy and lactation: Analysis of the WHO pharmacovigilance database”35
An altered reward system characterizes chronic migraine with medication overuse headache34
Pain sensitivities predict prophylactic treatment outcomes of flunarizine in chronic migraine patients: A prospective study32
Childhood and adolescent headache: A problem not to be ignored in the era of new therapies31
Triptan non-response in a London tertiary headache centre: What can we learn? A retrospective study30
Paroxysmal hemicrania and hemicrania continua: Review on pathophysiology, clinical features and treatment30
CGRP-antibodies, topiramate and botulinum toxin type A in episodic and chronic migraine: A systematic review and meta-analysis29
Effect of Altmetric score on manuscript citations: A randomized-controlled trial28
0.052181005477905